
Levocetirizine (5mg) + Montelukast (10mg)
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Febrikast LC Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, designed to provide effective relief from allergic conditions such as allergic rhinitis and chronic asthma. Levocetirizine is a second-generation antihistamine that works by selectively blocking peripheral H1 histamine receptors, thereby reducing symptoms like sneezing, runny nose, itching, and watery eyes. Montelukast, a leukotriene receptor antagonist, helps prevent airway inflammation and bronchoconstriction by inhibiting leukotriene D4 receptors in the lungs, making it particularly useful in managing asthma and seasonal allergies. The synergistic action of these two components offers comprehensive control over allergic symptoms and improves respiratory function. Febrikast LC is typically prescribed for patients who require both antihistaminic and anti-inflammatory effects to manage their allergy-related respiratory issues effectively. It is generally well-tolerated, but patients should use it under medical supervision, especially if they have a history of liver disease or other chronic conditions. Common side effects may include headache, fatigue, or gastrointestinal discomfort. Febrikast LC Tablet should be taken as directed by a healthcare professional to ensure optimal results and minimize potential adverse effects.
How to use Febrikast LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Febrikast LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Febrikast LC Tablet. Please consult your doctor.
High Risk
Febrikast LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Febrikast LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Febrikast LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Febrikast LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Febrikast LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Febrikast LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Febrikast LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Febrikast LC Tablet may be needed. Please consult your doctor. Use of Febrikast LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Febrikast LC Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Febrikast LC Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, designed to provide effective relief from allergic conditions such as allergic rhinitis and chronic asthma. Levocetirizine is a second-generation antihistamine that works by selectively blocking peripheral H1 histamine receptors, thereby reducing symptoms like sneezing, runny nose, itching, and watery eyes. Montelukast, a leukotriene receptor antagonist, helps prevent airway inflammation and bronchoconstriction by inhibiting leukotriene D4 receptors in the lungs, making it particularly useful in managing asthma and seasonal allergies. The synergistic action of these two components offers comprehensive control over allergic symptoms and improves respiratory function. Febrikast LC is typically prescribed for patients who require both antihistaminic and anti-inflammatory effects to manage their allergy-related respiratory issues effectively. It is generally well-tolerated, but patients should use it under medical supervision, especially if they have a history of liver disease or other chronic conditions. Common side effects may include headache, fatigue, or gastrointestinal discomfort. Febrikast LC Tablet should be taken as directed by a healthcare professional to ensure optimal results and minimize potential adverse effects.
How to use Febrikast LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Febrikast LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Febrikast LC Tablet. Please consult your doctor.
High Risk
Febrikast LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Febrikast LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Febrikast LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Febrikast LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Febrikast LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Febrikast LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Febrikast LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Febrikast LC Tablet may be needed. Please consult your doctor. Use of Febrikast LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Febrikast LC Tablet















